Updated:
Oslotech
Oslotech was established in 1984 by the University of Oslo (33.4% owner), the Industrial Development Corporation of Norway (SIVA, 30.5%), and the City of Oslo...
Oslotech
Oslotech was established in 1984 by the University of Oslo (33.4% owner), the Industrial Development Corporation of Norway (SIVA, 30.5%), and the City of Oslo (11%) alongside industrial shareholders including GE Healthcare, Norsk Hydro, Akastor, Aker Capital, and Elkem. The structure reflects a public-private mandate to bridge academic research and commercial industry. Karl-Christian Agerup served as CEO from 2010 to 2020, succeeded by Bjørn Erik Reinseth. The firm operates through a dual structure. Oslo Science Park, at Gaustadalléen 21, houses more than 3,000 professionals across 300-plus businesses, from startups and incubators to established research clusters. Adjacent to Oslo University Hospital and the University of Oslo, the campus provides wet labs, offices, and testing environments. On the capital side, Oslotech co-manages Springfondet, a venture fund in partnership with Kistefos, targeting early-stage research-driven companies. Confirmed co-investors and shareholders include GE Healthcare and Norsk Hydro. The firm focuses on Norway, with tenants and research collaborations rooted in the Oslo life-science and technology corridor. Oslotech employs a team of unspecified size and operates a single campus in Oslo. It functions as a non-dividend-paying company; all surplus from its real estate operations is reinvested into scientific facilities, maintenance, and innovation programs. In July 2026, ISS will assume operation of the campus food-service offering, with plans to upgrade quality and concept development. The firm has not disclosed total assets under management or aggregate investment deployment. Oslotech's structural differentiator is its zero-dividend, full-reinvestment model codified in its corporate charter. Unlike typical university tech-transfer offices or commercial science-park landlords, its ownership consortium binds public research institutions, municipal government, and industrial shareholders into a single vehicle that uses real estate income to subsidize early-stage commercialization — the science park is itself the endowment.
General information
Firm type
Single Family Office
Year founded
1984
AUM
Undisclosed
Location
Region
Europe
Country
Norway
City
Oslo
Corporate office
Gaustadalléen 21, 0349 Oslo, Norway
Principals
Bjørn Erik Reinseth
CEO
Sector focus
Frequently asked questions
Who owns Oslotech, and how does its ownership shape its mandate?
Oslotech AS is owned by the University of Oslo (33.4%), SIVA (30.5%), and the City of Oslo (11%), with minority stakes held by industrial shareholders including GE Healthcare, Norsk Hydro, Akastor, Aker Capital, and Elkem. Its charter prohibits dividend payouts; all surplus from its property operations is reinvested into the science park and innovation activities. This public-private, non-dividend structure aligns the consortium around long-term research commercialization rather than quarterly returns.
How does Oslotech deploy capital into startups?
Oslotech co-manages Springfondet, a venture fund operated in partnership with Kistefos. The fund targets early-stage, research-driven companies, primarily within Norway. Beyond fund commitments, Oslotech provides infrastructure through Oslo Science Park, offering wet labs and co-working spaces that lower the operating costs for portfolio companies and other tenants.
What is the relationship between Oslotech and the University of Oslo?
The University of Oslo is the largest single shareholder in Oslotech AS, holding a 33.4% stake. The science park sits adjacent to the university campus and Oslo University Hospital, making it the physical and programmatic gateway for spinning out academic research into commercial ventures. Faculty, researchers, and students routinely launch companies that take up residence inside the park.
Does Oslotech invest outside of Norway?
Known activities and tenant composition are concentrated in Norway, specifically the Oslo life-science and technology cluster. The firm's shareholder base is Norwegian, and its venture fund Springfondet targets domestic early-stage opportunities. Cross-border investment or international campus expansion has not been publicly disclosed.
Which industries does Oslotech focus on?
The science park's tenant mix and the Springfondet mandate point to life sciences, healthcare, climate technology, and industrial technology. Confirmed shareholders from the industrial sector — Norsk Hydro, Elkem, Akastor — signal a structural link to energy, materials, and industrial services, though specific portfolio allocations have not been disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: